The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

類似資料

• The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cancer: Current Status
  著者:: Meyerhardt, Jeffrey A., 等
  出版事項: (2014)
• The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
  著者:: Sobrero, A, 等
  出版事項: (2018)
• Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
  著者:: Grothey, A., 等
  出版事項: (2018)
• Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
  著者:: André, Thierry, 等
  出版事項: (2020)
• Efficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy
  著者:: Chen, Shi, 等
  出版事項: (2012)